SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000875320-24-000146
Filing Date
2024-05-17
Accepted
2024-05-17 16:16:42
Documents
3
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1715976969.html 3  
1 FORM 3 wk-form3_1715976969.xml 3 1652
2 EX-24 section16poajs.htm EX-24 4007
3 GRAPHIC section16poajs001.jpg GRAPHIC 240003
  Complete submission text file 0000875320-24-000146.txt   337763
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIVONGO HEALTH, INC. 150 WEST EVELYN AVENUE, SUITE 150 MOUNTAIN VIEW CA 94041
Business Address
Schneider Jennifer (Reporting) CIK: 0001783060 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 24959936